46 related articles for article (PubMed ID: 1369677)
1. Drug discrimination used to study drug withdrawal.
Emmett-Oglesby MW; Rowan GA
NIDA Res Monogr; 1991; (116):337-57. PubMed ID: 1369677
[No Abstract] [Full Text] [Related]
2. Conflicting evidence regarding the efficacy of ondansetron in benzodiazepine withdrawal.
Prather PL; Rezazadeh SM; Lane JD; Rowan GA; Hooper ML; Lytle DA; Emmett-Oglesby MW; Lal H
J Pharmacol Exp Ther; 1993 Feb; 264(2):622-30. PubMed ID: 8094750
[TBL] [Abstract][Full Text] [Related]
3. Tolerance, cross-tolerance and withdrawal in rats made dependent on diazepam.
Pugh SL; Boone MS; Emmett-Oglesby MW
J Pharmacol Exp Ther; 1992 Aug; 262(2):751-8. PubMed ID: 1501120
[TBL] [Abstract][Full Text] [Related]
4. Withdrawal from benzodiazepine dependence as a discriminative stimulus.
Emmett-Oglesby MW; Mathis DA
NIDA Res Monogr; 1989; 95():284. PubMed ID: 2518133
[No Abstract] [Full Text] [Related]
5. Bioassay of subjective effects associated with benzodiazepine withdrawal in animals: a novel direction in dependence research.
Emmett-Oglesby MW; Spencer DG; Lewis MW; Lal H
NIDA Res Monogr; 1984 Mar; 49():185-91. PubMed ID: 6434958
[No Abstract] [Full Text] [Related]
6. Withdrawal from diazepam substitutes for the discriminative stimulus properties of pentylenetetrazol.
Emmett-Oglesby MW; Mathis DA; Harris CM; Idemudia SO; Lal H
J Pharmacol Exp Ther; 1988 Mar; 244(3):892-7. PubMed ID: 3150850
[TBL] [Abstract][Full Text] [Related]
7. Abecarnil used to treat benzodiazepine withdrawal.
Emmett-Oglesby MW; Lytle DA; English SA
Psychopharmacol Ser; 1993; 11():121-31. PubMed ID: 7908431
[No Abstract] [Full Text] [Related]
8. Flumazenil prevents the development of chlordiazepoxide withdrawal in rats tested in the social interaction test of anxiety.
Baldwin HA; File SE
Psychopharmacology (Berl); 1989; 97(3):424-6. PubMed ID: 2497494
[TBL] [Abstract][Full Text] [Related]
9. Characterization of a pentylenetetrazol-like interoceptive stimulus produced by ethanol withdrawal.
Lal H; Harris CM; Benjamin D; Springfield AC; Bhadra S; Emmett-Oglesby MW
J Pharmacol Exp Ther; 1988 Nov; 247(2):508-18. PubMed ID: 3183950
[TBL] [Abstract][Full Text] [Related]
10. Benzodiazepines: drug discrimination and physiological dependence.
Griffiths RR; Ator NA; Lukas SE; Lamb RJ; Brady JV
NIDA Res Monogr; 1984 Mar; 49():163-4. PubMed ID: 6148692
[No Abstract] [Full Text] [Related]
11. Stereoselective discriminative stimulus effects of zopiclone in rhesus monkeys.
McMahon LR; Jerussi TP; France CP
Psychopharmacology (Berl); 2003 Jan; 165(3):222-8. PubMed ID: 12434260
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic characterization of acute chlordiazepoxide dependence in the rat.
Boisse NR; Periana RM; Guarino JJ; Kruger HS; Samoriski GM
J Pharmacol Exp Ther; 1986 Dec; 239(3):775-83. PubMed ID: 3098961
[TBL] [Abstract][Full Text] [Related]
13. Ethanol and chlordiazepoxide cross-dependence.
Chan AW
Alcohol Alcohol Suppl; 1987; 1():423-7. PubMed ID: 3122773
[TBL] [Abstract][Full Text] [Related]
14. Discrimination of the benzodiazepine receptor antagonist Ro 15-1788 using the conditioned taste aversion procedure.
Rowan GA; Lucki I
NIDA Res Monogr; 1989; 95():536. PubMed ID: 2561852
[No Abstract] [Full Text] [Related]
15. [Discrimination reversal learning in rats under the treatment of chlordiazepoxide: effect of overtraining].
Ichitani Y; Iwasaki T
Shinrigaku Kenkyu; 1984 Aug; 55(3):176-80. PubMed ID: 6503053
[TBL] [Abstract][Full Text] [Related]
16. [Effect of scopolamine on learning, in rats in a special type of maze].
Pazzagli A; Benvenuti P; Binazzi A; Cantini A
Riv Patol Nerv Ment; 1968 Dec; 89(6):571-86. PubMed ID: 5760470
[No Abstract] [Full Text] [Related]
17. Specific antagonism of the behavioral effects of chlordiazepoxide and pentobarbital in the rat.
Schechter MD
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(3):359-64. PubMed ID: 6435177
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological aspects of withdrawal from certain benzodiazepines.
Nowakowska E; Chodera A; Kus K
Pol J Pharmacol; 1997; 49(2-3):89-95. PubMed ID: 9437755
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anxiolytic action of ondansetron in rats during withdrawal from chronic chlordiazepoxide.
Rezazadeh SM; Prather PL; Emmett-Oglesby MW; Lal H
Ann N Y Acad Sci; 1992 Jun; 654():472-3. PubMed ID: 1352955
[No Abstract] [Full Text] [Related]
20. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
